Lang C H, Bagby G J, Blakesley H L, Spitzer J J
Department of Physiology, Louisiana State University Medical Center, New Orleans 70112.
Circ Shock. 1987;23(2):131-41.
Decreased pyruvate dehydrogenase (PDH) activity in skeletal muscle has been observed during sepsis and may contribute to the altered glucose kinetics seen in this condition. The purpose of the present study was to determine if dichloroacetate (DCA), a known stimulator of PDH activity, could reverse the sepsis-induced increase in glucose metabolism. Hypermetabolic sepsis was produced in chronically catheterized rats by repeated subcutaneous injections of live Escherichia coli. Whole body glucose kinetics, assessed by a constant iv infusion of [6-3H and U-14C]-glucose, were determined in fasted septic and nonseptic rats before and for 4 hr after an injection of DCA (30 mg/100 g BW, iv). Sepsis produced hyperthermia (+1.6 degrees C) and increased the rates of glucose appearance (Ra; 95%), recycling (318%), metabolic clearance (MCR; 114%), and elevated plasma lactate levels (295%) compared to nonseptic controls. After injection of DCA into septic rats, glucose levels gradually fell, and the sepsis-induced hyperlactacidemia was completely reversed. Treatment of septic rats with DCA reversed the elevated glucose Ra; recycling, although reduced, was still elevated by 50% compared to control animals. DCA did not alter the hyperglucagonemia seen in septic animals, but it did reduce the plasma insulin levels by 60%. Hepatic and muscle PDH activities were not different in saline-treated septic and nonseptic animals. DCA elevated PDH activity in muscle from septic rats, but the increase was smaller than that seen in control animals. This may explain the smaller decline in glucose recycling and plasma lactate in septic animals. These results are consistent with DCA reducing the elevated glucose Ra in sepsis by partial activation of PDH, which reduces the elevated precursor (lactate) supply for gluconeogenesis. However, alterations in PDH activity did not appear to contribute to the underlying increase in glucose Ra and recycling observed in sepsis.
在脓毒症期间已观察到骨骼肌中丙酮酸脱氢酶(PDH)活性降低,这可能是导致该病症中葡萄糖动力学改变的原因之一。本研究的目的是确定二氯乙酸(DCA),一种已知的PDH活性刺激剂,是否能够逆转脓毒症诱导的葡萄糖代谢增加。通过反复皮下注射活的大肠杆菌,在长期插管的大鼠中诱发高代谢性脓毒症。在禁食的脓毒症大鼠和非脓毒症大鼠中,在注射DCA(30mg/100g体重,静脉注射)之前和之后4小时,通过持续静脉输注[6-³H和U-¹⁴C]-葡萄糖来测定全身葡萄糖动力学。与非脓毒症对照组相比,脓毒症导致体温升高(+1.6摄氏度),葡萄糖出现率(Ra)增加(95%)、再循环率增加(318%)、代谢清除率(MCR)增加(114%),并且血浆乳酸水平升高(295%)。向脓毒症大鼠注射DCA后,葡萄糖水平逐渐下降,脓毒症诱导的高乳酸血症完全逆转。用DCA治疗脓毒症大鼠可逆转升高的葡萄糖Ra;再循环率虽然降低,但与对照动物相比仍升高50%。DCA并未改变脓毒症动物中出现的高胰高血糖素血症,但它确实使血浆胰岛素水平降低了60%。在生理盐水处理的脓毒症动物和非脓毒症动物中,肝脏和肌肉的PDH活性没有差异。DCA提高了脓毒症大鼠肌肉中的PDH活性,但增加幅度小于对照动物。这可能解释了脓毒症动物中葡萄糖再循环和血浆乳酸下降幅度较小的原因。这些结果与DCA通过部分激活PDH来降低脓毒症中升高的葡萄糖Ra一致,这减少了糖异生中升高的前体(乳酸)供应。然而,PDH活性的改变似乎并未导致脓毒症中观察到的葡萄糖Ra和再循环的潜在增加。